7 Undervalued Financial Companies to Add to Your Portfolio

Take note of these low-priced diamond-in-the-rough financial stocks that analysts are projecting to boom in the future. By taking advantage of timing, you can position yourself for a massive windfall.

By clicking the link above you will automatically opt-in to receive emails from MarketHundred

VNDA
Vanda Pharmaceuticals Inc
NASDAQ
5.11
Open 5.41 Prev Close 5.27
High 5.48 Low 5.26
Volume 685,600 Volume (Avg) 2,162,050
52 Week High 20.51 52 Week Low 7.86
Market Cap 935.2M PE Ratio -62.73

Shares Stats

Shares Outstanding54,882,700
Shares Float39,601,168
Shares Short5,141,909
Insider Holdings327%
Institution Holdings101.49%

About Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under development include HETLIOZ (tasimelteon) for the treatment of jet lag disorder, smith-magenis syndrome, pediatric Non-24, autism spectrum, and delayed sleep phase disorder; Fanapt (iloperidone) for the treatment of bipolar disorder and a long acting injectable formulation program for the treatment of schizophrenia; and Tradipitant (VLY-686), a small molecule neurokinin-1 receptor (NK-1R) antagonist, for the treatment of atopic dermatitis, gastroparesis, and motion sickness. The company's products under development also comprise VTR-297, a small molecule histone deacetylase inhibitor for the treatment of hematologic malignancies and with potential use as a treatment for various oncology indications; VQW-765, a small molecule nicotinic acetylcholine receptor partial agonist for the treatment of psychiatric disorders; and a portfolio of cystic fibrosis transmembrane conductance regulator activators and inhibitors for the treatment of dry eye and ocular inflammation, as well as BPO-27 for the treatment of secretory diarrhea disorders, including cholera. It markets its products in the United States, Europe, and Israel. Vanda Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in Washington, the District of Columbia.

General

NameVanda Pharmaceuticals Inc
TickerVNDA
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
CurrencyUSD
CountryUSA
Fiscal Year EndDecember
Full Time Employees292

Highlights

Analyst Target21
Market Cap935,201,280
PE Ratio-62.73
PEG Ratio-2.42
EBITDA30,103,000

Financials

Curr Year EPS Estimate0.51
Next Quarter EPS Estimate0.16
Profit Margin0.09
Return on Assets0.03
Return on Equity0.05
Revenue248,168,000
Earnings Per Share0.42
Revenue Per Share4.56
Gross Profit224,804,000
Quarterly Revenue Growth0.11

Valuation

Trailing PE40.57
Forward PE30.30
Price/Sales (Trailing 12 Mt.)3.90
Price/Book (Most Recent Quarter)2.12

Earnings

Most Popular

Central Banks Buying Gold in Record Numbers - Ad

Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can... Stacking it in their locked vaults on pallets in record numbers. Find out why right here (and see what you can do to get in too with just a few dollars).

Australia Calls For Inquiry Into Meta's Facebook, Elon Musk's X, TikTok To 'Make These Platforms Accountable For Their Decisions'

The Australian government has expressed concerns over the lack of regulation and oversight on social media platforms, which have a significant impact on the content viewed by Australians. The inquiry will specifically focus on the platforms' handling of violent content and their withdrawal from paying for news in Australia.

Could Elon's New Device be Bigger than the iPhone? - Ad

According to 30-year Silicon Valley and Wall Street veteran, Eric Fry... A man who picked 41 plays that jumped 1,000%+... This mind-blowing new technology could be bigger than the iPhone. And it could make a lot of people wealthy in the coming months and years.

Buffett Says No Other Americans Would Have Had To Pay Even A Dime In Federal Taxes If This Had Happened

Warren Buffett suggests that federal taxes will likely increase given the country's precarious fiscal position, and he expressed Berkshire's willingness to cover the tax bill it faces.

Shhh! This Is One Great Coin... - Ad

Shhh! I truly believe this crypto could be one of the top earning cryptos of all time... In fact, in the coming bull run... this one coin could have the potential to bank 10x... 50x... and even 100x.

Elon Musk Issues Stark Warning Amid Rising National Debt: '...The Dollar Will Be Worth Nothing'

Elon Musk has voiced concerns about the future stability of the U.S. dollar, highlighting the escalating national debt as a potential catalyst for a looming economic crisis.

Demand Soars For Novo Nordisk's Weight-Loss Drug Wegovy Despite Supply Constraints And Eli Lilly Competition

The Danish pharmaceutical company is now shipping more introductory doses of Wegovy to the U.S., as it grapples with supply constraints and competition from Eli Lilly.

Mystery of the Rich and Connected Revealed - Ad

Former Goldman VP reveals a mysterious "Gold Bank" with huge upside potential... Last time we shared this, some folks could have seen a 995% gain. Don't be surprised if you've never heard of this -- most haven't. But he's sharing all in this new video.

James Simons, mathematician, philanthropist and hedge fund founder, has died

James “Jim” Simons, a renowned mathematician and pioneering investor who built a fortune on Wall Street and then became one of the nation's biggest philanthropists, has died at age 86.

Maker of popular weedkiller amplifies fight against cancer-related lawsuits

JEFFERSON CITY, Mo. (AP) — After failing in several U.S. states this year, global chemical manufacturer Bayer said Tuesday that it plans to amplify efforts to create a legal shield against a proliferation of lawsuits alleging it failed to warn that its popular weedkiller could cause cancer.

Don't Miss the Next AI Payout Opportunity (It's Coming Soon) - Ad

Louis Navellier recently revealed a unique way to tap into the AI craze without buying any of the big names like Amazon, Google, or Facebook. It involves a series of consistent, retirement-boosting payouts, and the next one is coming soon.

Nvidia Joins $1.05B Wayve Funding, Advances Automated Driving

Wayve secures $1.05 billion funding, spearheaded by Nvidia and SoftBank, to revolutionize autonomous driving. CEO Alex Kendall's strategy prioritizes adaptable AI, setting the stage for Wayve's expansion and profitability.

Troubled EV Maker Fisker Said To Shut Down California HQ And Relocate Some Staff As Bankruptcy Clock Ticks

Some employees at the Manhattan Beach office have been informed of the relocation and have been asked to prepare for the move by collecting their belongings.

The Biggest Year in Crypto Is Here... Right Now - Ad

The LAST bull run in crypto handed out 4 and 5-figure returns... This time the odds are stacked even better in our favor. 19 Wall Street banks are pouring millions into crypto right now... Blackrock Financial has gone ALL IN and is already breaking records with their investment. $100 trillion in Wall Street money is just waiting to be deployed. The only thing missing... is you.

Once Vehicles For Republican Presidents To Connect With Southern Whites, Motor Sports Are Shifting Away From Trump

The fading sway of Trump in motor sports suggests the breakup of the conservative-racing connection, as shown by recent developments at the Miami Grand Prix.

Should You Buy Bitcoin in 2024? [Expert's Shocking Answer] - Ad

Bitcoin minted 100,000 millionaires and if you're not one of them, that ship has sailed. But there's another millionaire-minting crypto at our doorstep... research shows this coin could be 20X bigger than Bitcoin by the end of the decade. With crypto starting to heat up again, this could be the perfect time to get in.

Jim Cramer Advises Investors To Stick With Good Companies Despite Short-Term Losses: 'You Just Need To Figure Out Which Companies Deserve Your Confidence'

Cramer, a prominent figure in the finance world, suggested that investors should not emulate the trading habits of large hedge funds. Instead, he recommended a long-term investment strategy, emphasizing the need to anticipate and endure market declines.

Cannabis Company TerrAscend Posts Q1 2024 Gains In Revenue And Operational Efficiency

TerrAscend Corp. (OTC: TSNDF), a cannabis company with a presence in several states, reported its financial performance for the first quarter that ended March 31, 2024 with gains in revenue and operational efficiency.

Nvidia CEO Says It Will Spark "the Next Revolution" Beyond AI - Ad

Declares this radical biotechnology "is going to be flat out one of the biggest [tech revolutions] ever." And this $10 stock is at the center of all.

Why Sprout Social Shares Got Crushed Friday

Shares of Sprout Social fell Friday after reporting first-quarter financial results Thursday and sharing Q2 guidance.Cloud software company Sprout Social (NASDAQ:SPT) saw shared fell 40% Friday after reporting first-quarter financial results Thursday.

Boeing locks out its private firefighters around Seattle over pay dispute

Boeing has its private force of firefighters who protect its in the Seattle area and brought in replacements after the latest round of negotiations with the firefighters' union failed to deliver an agreement on wages.

One Coin to Rule Them All... - Ad

Hardly any investors are talking about this coin but I believe that's about to change with some potentially huge news! Get in on the ground floor while it's rock bottom with this new how-to guide, just $3.

Your tax refund could be bigger this year. Here's what to do with it

NEW YORK (AP) — The average taxpayer is getting a $2,852 refund, $75 more than last year, based on the most recent IRS data. So what should you ?

California is testing new generative AI tools. Here's what to know

SACRAMENTO, Calif. (AP) — Generative artificial intelligence tools will soon be used by California's government.

Must-See: Elon's New Invention is Absolutely Insane - Ad

When you click here and see what Elon Musk's new invention does... And how it works... You will NOT believe it. You'll tell yourself this is just science fiction. But Elon just tested this in a real human... And the result was mind-blowing.

As 'Roaring Kitty' Returns, Here Are 3 ETFs To Leverage The 2024 Meme Stock Wave

Meme stocks, led by Keith Gill, have resurfaced on social media, causing GameStop's stock to surge by 74% and AMC's by 80%. ETFs like ARCA:STCE can capitalize on this trend.

Disney receives key approval to expand Southern California theme parks

ANAHEIM, Calif. (AP) — Disney has received a key approval to expand its Southern California theme parks in its first push to make major changes to its iconic Disneyland in decades.

PASSIVE INCOME (by this evening) - Ad

Hey, I have an unique opportunity for those looking for additional ways to earn income right now. It can be done from home. You can do it in your spare time. And it only takes 6 clicks and as little as $50.

How to turn a supermarket bouquet into a lusher, more personalized flower arrangement

If your heart is telling you to give someone a luxurious bouquet of flowers, but your wallet is telling you to shop at the supermarket, fear not: With a bit of imagination and creativity, you can transform a simple, low-cost bouquet into a stunning floral arrangement.

Shell Exits Chinese Power Market, Eyes Gas Growth: Report

Shell reportedly exits China's power markets, focusing on bolstering profitability in natural gas and oil sectors. The move reflects a commitment to invest selectively in profitable ventures within the power sector, aligning with CEO Wael Sawan's vision.

22 Countries Pledge To 3X Nuclear Power - Uranium Prices Soar 74% - Ad

Newswire says "Bull market continues in Uranium stocks." Who to pick? Well, exploration records show...

Italy Based Stevanato Reports Mixed Q1 Earnings, Revises Annual Guidance On Temporary Destocking

Stevanato Group reports Q1 earnings of 236.0 million euros, down 1% Y/Y. Sales declined due to vial destocking amid pandemic effects. High-value solutions revenue up to 37% driven by syringe demand. Updated FY24 guidance reflects cautious outlook.

Warren Buffett Was Right! America's Billionaires Now Pay Lower Tax Rate Than Working Class For First Time Ever, New Analysis Shows

According to economist Gabriel Zucman, the effective tax rate of the 400 richest Americans in 2018 was 23%, slightly lower than the 24% rate for the bottom half of income earners. 

Buy This Next Gen Crypto Before Its Big Upgrade - Ad

Experts predict this one crypto will soar 7,200% by the end of the decade... and grow 20X bigger than bitcoin. But you must get in before it's big.

Snowflake Analysts Remain Overweight: Potential Growth Despite Iceberg Adoption Concerns

Piper Sandler analyst attended Virtual Iceberg Summit with tech giants. Snowflake seen as having potential drag on growth, but threat may be overstated.

Most Recent

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright trendadvisor.net
Privacy Policy | Terms of Service